Abstract
A total of 598 clinical isolates of anaerobic bacteria were tested against ciprofloxacin by the agar dilution technique with 10(5) CFU on Wilkins-Chalgren medium. Selected strains representative of the six major genera of anaerobes relatively resistant to the quinolones were tested for interactions with ciprofloxacin in combination with clindamycin, metronidazole, cefoxitin, cefotaxime, or mezlocillin by using a checkerboard agar dilution technique. Cefotaxime-ciprofloxacin and clindamycin-ciprofloxacin were the most effective combinations, with 16% of all isolates and 44% of the Bacteroides fragilis group isolates responding synergistically to the former combination and 9% of all isolates and 37% of Peptostreptococcus isolates responding synergistically to the latter. Occasional synergy was seen with all other antibiotic combinations except for metronidazole-ciprofloxacin. Likewise, synergism was seen with all groups of anaerobes except for Fusobacterium species. Antagonistic interactions were observed only with a Peptostreptococcus intermedius strain tested against clindamycin-ciprofloxacin. These data suggest that combinations of ciprofloxacin with these agents may be useful for certain resistant anaerobic infections.
MeSH Terms
Bacteria, Anaerobic/drug effects
Cefotaxime/administration & dosage
Cefoxitin/administration & dosage
Ciprofloxacin/administration & dosage
Drug Interactions
Drug Synergism
Gram-Negative Anaerobic Bacteria/drug effects
Gram-Positive Bacteria/drug effects
In Vitro Techniques
Metronidazole/administration & dosage
Mezlocillin/administration & dosage
Chemicals
Metronidazole
Ciprofloxacin
Cefoxitin
Cefotaxime
Mezlocillin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Whiting J L
Department of Medicine, University of British Columbia, Vancouver, Canada.
Cheng N
Chow A W
References (12)
12 references, click to expand
-
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64
PMID: 6222695
-
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Antimicrob Agents Chemother. 1984 Mar;25(3):342-3
PMID: 6721466
-
The in vitro and in vivo activity of ciprofloxacin.
Eur J Clin Microbiol. 1984 Aug;3(4):339-43
PMID: 6237902
-
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Eur J Clin Microbiol. 1984 Aug;3(4):372
PMID: 6593220
-
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids.
Eur J Clin Microbiol. 1984 Aug;3(4):373
PMID: 6489330
-
Tissue penetration of ciprofloxacin after single and multiple doses.
Antimicrob Agents Chemother. 1986 Mar;29(3):501-5
PMID: 2940974
-
Comparative activity of ciprofloxacin against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 Mar;27(3):427-8
PMID: 3158278
-
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9
PMID: 3847273
-
Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.
Antimicrob Agents Chemother. 1985 Nov;28(5):663-6
PMID: 2936301
-
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Antimicrob Agents Chemother. 1985 Aug;28(2):331-42
PMID: 2939797
-
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
Antimicrob Agents Chemother. 1986 Mar;29(3):386-8
PMID: 2940969
-
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
Antimicrob Agents Chemother. 1984 Nov;26(5):785-6
PMID: 6517561